• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型抗肿瘤抗生素——孢子霉素的抗肿瘤活性

Antitumor activity of a new antitumor antibiotic, sporamycin.

作者信息

Komiyama K, Takeshima H, Umezawa I

出版信息

Gan. 1977 Apr;68(2):213-9.

PMID:892295
Abstract

Sporamycin is an antitumor antibiotic isolated from the culture filtrate of Streptosporangium strain No. PO-357. Hydrolysate of the antibiotic showed at least 12 kinds of amino acid, and the molecular weight was calculated approximately as 8,500 approximately 9,000. Antitumor activities of Sporamycin were examined on murine tumors according to different schedules of treatment. After nine daily doses of the antibiotic had been given to dd mice bearing Ehrlich ascites carcinoma, significant increase of lifespan was observed at doses of 5.0 approximately 1.3 mg/kg. A marked decrease in tumor size of sarcoma-180 transplanted subcutaneously was observed when the mice were treated by daily or single injection of Sporamycin. Against leukemia P-388 and L-1210 inoculated intraperitoneally into CDF1 mice, the antibiotic increased lifespan of leukemic mice. The antibiotic also inhibited significantly the growth of human tumor cells in vitro.

摘要

孢子霉素是从链孢囊菌属PO - 357菌株的培养滤液中分离出的一种抗肿瘤抗生素。该抗生素的水解产物显示至少有12种氨基酸,分子量经计算约为8500至9000。根据不同的治疗方案,对孢子霉素的抗肿瘤活性在小鼠肿瘤上进行了检测。给患有艾氏腹水癌的dd小鼠每日注射九次该抗生素后,在剂量为5.0至1.3毫克/千克时观察到寿命显著延长。当通过每日或单次注射孢子霉素治疗小鼠时,皮下移植的肉瘤 - 180肿瘤大小明显减小。对于腹腔接种到CDF1小鼠体内的白血病P - 388和L - 1210,该抗生素延长了白血病小鼠的寿命。该抗生素在体外也显著抑制人肿瘤细胞的生长。

相似文献

1
Antitumor activity of a new antitumor antibiotic, sporamycin.一种新型抗肿瘤抗生素——孢子霉素的抗肿瘤活性
Gan. 1977 Apr;68(2):213-9.
2
[Use of the probit method for the evaluation of the effectiveness of rubomycin in the treatment of transplantable tumors in mice].
Antibiotiki. 1971;16(8):714-8.
3
[Experimental study of antitumor activity of the antibiotic bruneomycin].
Antibiotiki. 1966 Aug;11(8):683-91.
4
[Production conditions and properties of the new antineoplastic antibiotic No. 294].[新型抗肿瘤抗生素294号的生产条件与性质]
Antibiotiki. 1970 Aug;15(8):675-8.
5
[A new antibiotic with antineoplastic activity: rubidomycin (13.057 R.P.). II. Experimental antitumor activity].一种具有抗肿瘤活性的新型抗生素:柔红霉素(13.057 R.P.)。II. 实验性抗肿瘤活性
Arzneimittelforschung. 1967 Aug;17(8):939-48.
6
Iyomycin, a new antitumor antibiotic from Streptomyces. IV. Experimental treatment of malignant tumors with iyomycins.
J Antibiot (Tokyo). 1967 Jan;20(1):20-40.
7
[Experimental study of antitumor activity of antibiotic tavromycetin].
Antibiotiki. 1967 May;12(5):355-60.
8
Antitumor effect of a new antibiotic, neothramycin.
Gan. 1980 Jun;71(3):308-12.
9
[Experimental study of the antineoplastic activity of the antibiotic reumycin].
Antibiotiki. 1967 Oct;12(10):892-8.
10
[Antineoplastic effect of the antibiotics rubomycin B and C in experimental conditions].
Antibiotiki. 1969;14(3):249-54.

引用本文的文献

1
Histopathological studies on antitumor effect of sporamycin. Cell-mediated immunity against allogeneic tumor-bearing mice.孢子霉素抗肿瘤作用的组织病理学研究。对同种异体荷瘤小鼠的细胞介导免疫。
Cancer Chemother Pharmacol. 1980;5(2):113-8. doi: 10.1007/BF00435414.